Precision Medicine Data Integration Core
Precision Medicine Data Integration Core
批准号:
10487446
负责人:
CLIFTON O BINGHAM
金额:
$21.28万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
未结题
起止时间:
2016-09-09 至 2026-06-30
关键词:
AddressAreaBig DataBiologic CharacteristicCOVID-19CharacteristicsClinicalClinical ResearchCollaborationsComplexConsentDataData AggregationData AnalysesData CollectionData ScienceData SecurityData SourcesDatabasesDevelopmentDiseaseDocumentationEnsureEnvironmentEventFacultyFosteringFoundationsHealthcareHeterogeneityImageImaging DeviceInfrastructureInstitutionInstitutional Review BoardsKineticsLaboratory ProceduresLearningLupusMalignant NeoplasmsMeasurementMedical DeviceMedicineMethodsMyositisOutcome MeasureParticipantPathogenesisPathway interactionsPatient CarePatient Outcomes AssessmentsPatientsPatternPhenotypePrecision Medicine InitiativeProtocols documentationPsoriatic ArthritisQuality of lifeRegistriesRegulationResearchResearch EthicsResearch PersonnelResourcesRheumatismRheumatoid ArthritisRheumatologyRiskSclerodermaSecureSjogren&aposs SyndromeSpeedStandardizationSystemTechniquesTechnologyTelemedicineTherapeuticTimeUniversitiesVasculitisWorkanalytical toolbasebiobankclinically relevantcohortcommon ruledata acquisitiondata harmonizationdata integrationdata modelingdata pipelinedata streamsdiagnostic platformdigitaldisorder subtypeelectronic consentexperienceimmune-related adverse eventsimprovedinsightmultiple data sourcesnovelpatient subsetsphenotypic datapoint of careprecision medicineprogramsquantitative imagingrecruitresearch studyresponserisk stratificationscreeningtooltreatment responsewearable device
中文摘要
核心B精准医疗数据集成
项目总结
风湿性疾病在表型、事件动力学和轨迹上是不同的,并且
对治疗的反应。定义相对同质的疾病亚组可以促进识别
有相同的潜在病理生理机制、并发症风险和
对不同的治疗策略的反应-从而为开发
精准医学接近风湿病。作为利用多个
亚组患者的临床和生物学特征可能会改善我们的预测
能力,关键是利用允许聚合和协调的工具和技术
多数据流数据。约翰·霍普金斯医学公司已经建立了一个大数据捕获系统,
聚合和协调。这个工具被称为精准医学分析平台,
捕获高质量的纵向数据,包括护理点更深的表型数据,
来自诊断系统的细粒度结果和来自医疗保健之外的测量
环境。在这项提议中,我们寻求将这些工具和技术引入我们的风湿病
狼疮、血管炎、类风湿性关节炎、银屑病、硬皮病、
肌炎、干燥综合征、莱姆病和癌症免疫相关不良事件加速发生
风湿病的研究。精准医学数据集成的具体目标
核心是:1)促进和加快研究性学习的实施,同时确保严格
研究道德和数据安全实践;以及2)将数据收集方法转变为利用
制度性的大数据,提高效率,实现远程学习进度。核心由以下人员领导
研究项目建设、研究伦理和数据安全实践以及数据方面的专家
捕获和协调方法。
英文摘要
Core B Precision Medicine Data Integration
PROJECT SUMMARY
Rheumatic diseases are heterogeneous in phenotypes, kinetics of events and trajectory, and
response to therapy. Defining relatively homogenous disease subgroups can foster identification
of patients who share underlying pathophysiologic mechanisms, risks of complications and
response to distinct therapeutic strategies – thereby laying a critical foundation for developing
precision medicine approaches to the rheumatic diseases. As approaches that utilize multiple
clinical and biologic characteristics to subgroup patients will likely improve our predictive
capability, it is critical to harness tools and technologies that allow aggregation and harmonization
of multiple streams data. Johns Hopkins Medicine has built a system for big data capture,
aggregation and harmonization. This tool, known as the Precision Medicine Analytics Platform,
captures high quality longitudinal data including deeper phenotypic data at the point of care,
granular results from diagnostic systems and measurements from outside the health care
environment. In this proposal, we seek to bring these tools and technologies to our rheumatology
subspecialty centers in Lupus, Vasculitis, Rheumatoid Arthritis, Psoriatic Arthritis, Scleroderma,
Myositis, Sjogren’s syndrome, Lyme, and Cancer Immune-Related Adverse Events to accelerate
research in the rheumatic diseases. The Specific Aims of the Precision Medicine Data Integration
Core are to: 1) facilitate and accelerate research study implementation, while ensuring stringent
research ethics and data security practices; and 2) transform data collection methods to harness
institutional “big data,” improve efficiency and enable remote study progress. The Core is led by
experts in research program building, research ethics and data security practices, and data
capture and harmonization methods.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Johns Hopkins Rheumatic Diseases Resource-based Core Center (Johns Hopkins RDRCC)
-
批准号:10487438
-
项目类别:
-
资助金额:$80.8万
-
财政年份:2016
-
负责人:CLIFTON O BINGHAM
-
依托单位:
Johns Hopkins Rheumatic Diseases Resource-based Core Center
-
批准号:9752316
-
项目类别:
-
资助金额:$77.67万
-
财政年份:2016
-
负责人:CLIFTON O BINGHAM
-
依托单位:
Johns Hopkins Rheumatic Diseases Resource-based Core Center
-
批准号:9162939
-
项目类别:
-
资助金额:$81.34万
-
财政年份:2016
-
负责人:CLIFTON O BINGHAM
-
依托单位:
Precision Medicine Data Integration Core
-
批准号:10281311
-
项目类别:
-
资助金额:$20.44万
-
财政年份:2016
-
负责人:CLIFTON O BINGHAM
-
依托单位:
Johns Hopkins Rheumatic Diseases Resource-based Core Center (Johns Hopkins RDRCC)
-
批准号:10281309
-
项目类别:
-
资助金额:$81.77万
-
财政年份:2016
-
负责人:CLIFTON O BINGHAM
-
依托单位:
Periodontal Assessment in RA Study (PARAS)
-
批准号:7033758
-
项目类别:
-
资助金额:$8.18万
-
财政年份:2006
-
负责人:CLIFTON O BINGHAM
-
依托单位:
Core D - Human Subjects and Analytical Core
-
批准号:8535520
-
项目类别:
-
资助金额:$25.99万
-
财政年份:2006
-
负责人:CLIFTON O BINGHAM
-
依托单位:
Core D - Human Subjects and Analytical Core
-
批准号:8725580
-
项目类别:
-
资助金额:$26.76万
-
财政年份:2006
-
负责人:CLIFTON O BINGHAM
-
依托单位:
Core D - Human Subjects and Analytical Core
-
批准号:8913757
-
项目类别:
-
资助金额:$26.59万
-
财政年份:2006
-
负责人:CLIFTON O BINGHAM
-
依托单位:
Core D - Human Subjects and Analytical Core
-
批准号:8209371
-
项目类别:
-
资助金额:$28.13万
-
财政年份:2006
-
负责人:CLIFTON O BINGHAM
-
依托单位:
Periodontal Assessment in RA Study (PARAS)
-
批准号:7248818
-
项目类别:
-
资助金额:$7.96万
-
财政年份:2006
-
负责人:CLIFTON O BINGHAM
-
依托单位:
Core D - Human Subjects and Analytical Core
-
批准号:8380936
-
项目类别:
-
资助金额:$26.99万
-
财政年份:2006
-
负责人:CLIFTON O BINGHAM
-
依托单位:
DELAYED-TYPE HYPERSENSITIVITY RESPONSES IN DMARD-TREATED RHEUMATOID ARTHRITIS
-
批准号:7207108
-
项目类别:
-
资助金额:$4.2万
-
财政年份:2005
-
负责人:CLIFTON O BINGHAM
-
依托单位:
GLUCOSAMINE/CHONDROITIN ARTHRITIS INTERVENTION TRIAL (GAIT)
-
批准号:7207107
-
项目类别:
-
资助金额:$0.81万
-
财政年份:2005
-
负责人:CLIFTON O BINGHAM
-
依托单位:
Glucosamine/Chondroitin Arthritis Intervention Trial (GAIT)
-
批准号:6974347
-
项目类别:
-
资助金额:$1.09万
-
财政年份:2004
-
负责人:CLIFTON O BINGHAM
-
依托单位:
Delayed-Type Hypersensitivity Responses in DMARD-Treated Rheumatoid Arthritis
-
批准号:6974349
-
项目类别:
-
资助金额:$2.46万
-
财政年份:2004
-
负责人:CLIFTON O BINGHAM
-
依托单位:
Multidisciplinary Rheumatology Training Program
-
批准号:9924445
-
项目类别:
-
资助金额:$29.69万
-
财政年份:2003
-
负责人:CLIFTON O BINGHAM
-
依托单位:
Multidisciplinary Rheumatology Training Program
-
批准号:10633235
-
项目类别:
-
资助金额:$26.42万
-
财政年份:2003
-
负责人:CLIFTON O BINGHAM
-
依托单位:
Multidisciplinary Rheumatology Training Program
-
批准号:10403660
-
项目类别:
-
资助金额:$34.28万
-
财政年份:2003
-
负责人:CLIFTON O BINGHAM
-
依托单位:
Multidisciplinary Rheumatology Training Program
-
批准号:10203775
-
项目类别:
-
资助金额:$32.78万
-
财政年份:2003
-
负责人:CLIFTON O BINGHAM
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: